I agree that this site is using cookies. You can find further informations here.
X
Caravatti, Giorgio
42  results:
Search for persons X
?
1

Identification of NVP-CLR457 as an Orally Bioavailable Non-..:

Fairhurst, Robin A. ; Furet, Pascal ; Imbach-Weese, Patricia...
Journal of Medicinal Chemistry.  65 (2022)  12 - p. 8345-8379 , 2022
Link: https://doi.org/10.1021/..
 
?
2

Comparison of the Kinase Profile of Midostaurin (Rydapt) wi..:

Manley, Paul W. ; Caravatti, Giorgio ; Furet, Pascal...
Biochemistry.  57 (2018)  38 - p. 5576-5590 , 2018
Link: https://doi.org/10.1021/..
 
?
3

Discovery of Potent, Selective, and Structurally Novel Dot1..:

Möbitz, Henrik ; Machauer, Rainer ; Holzer, Philipp...
ACS Medicinal Chemistry Letters.  8 (2017)  3 - p. 338-343 , 2017
Link: https://doi.org/10.1021/..
 
?
4

Increasing metabolic stability via the deuterium kinetic is..:

Fairhurst, Robin A. ; Caravatti, Giorgio ; Guagnano, Vito...
Bioorganic & Medicinal Chemistry Letters.  26 (2016)  19 - p. 4729-4734 , 2016
Link: https://doi.org/10.1016/..
 
?
5

Discovery of Novel Dot1L Inhibitors through a Structure-Bas..:

Chen, Chao ; Zhu, Hugh ; Stauffer, Frédéric...
ACS Medicinal Chemistry Letters.  7 (2016)  8 - p. 735-740 , 2016
Link: https://doi.org/10.1021/..
 
?
6

Identification and optimisation of 4,5-dihydrobenzo[1,2-d:3..:

Fairhurst, Robin A. ; Gerspacher, Marc ; Imbach-Weese, Patricia...
Bioorganic & Medicinal Chemistry Letters.  25 (2015)  17 - p. 3575-3581 , 2015
Link: https://doi.org/10.1016/..
 
?
7

Identification and optimisation of a 4′,5-bisthiazole serie..:

Fairhurst, Robin A. ; Imbach-Weese, Patricia ; Gerspacher, Marc...
Bioorganic & Medicinal Chemistry Letters.  25 (2015)  17 - p. 3569-3574 , 2015
Link: https://doi.org/10.1016/..
 
?
8

Discovery of NVP-BYL719 a potent and selective phosphatidyl..:

Furet, Pascal ; Guagnano, Vito ; Fairhurst, Robin A....
Bioorganic & Medicinal Chemistry Letters.  23 (2013)  13 - p. 3741-3748 , 2013
Link: https://doi.org/10.1016/..
 
?
9

Corrigendum to "Discovery of NVP-BYL719 a potent and select..:

Furet, Pascal ; Guagnano, Vito ; Fairhurst, Robin A....
Bioorganic & Medicinal Chemistry Letters.  23 (2013)  16 - p. 4723 , 2013
Link: https://doi.org/10.1016/..
 
?
10

Entry into a new class of protein kinase inhibitors by pseu..:

Furet, Pascal ; Caravatti, Giorgio ; Guagnano, Vito...
Bioorganic & Medicinal Chemistry Letters.  18 (2008)  3 - p. 897-900 , 2008
Link: https://doi.org/10.1016/..
 
?
11

Structure–Activity Relationships in Side‐Chain‐Modified Epo..:

Bold, Guido ; Wojeik, Séverine ; Caravatti, Giorgio...
ChemMedChem.  1 (2006)  1 - p. 37-40 , 2006
Link: https://doi.org/10.1002/..
 
?
12

Protein kinases as targets for anticancer agents: from inhi..:

Fabbro, Doriano ; Ruetz, Stephan ; Buchdunger, Elisabeth...
Pharmacology & Therapeutics.  93 (2002)  2-3 - p. 79-98 , 2002
Link: https://doi.org/10.1016/..
 
?
13

The Total Synthesis and Biological Assessment of trans-Epot..:

Altmann, Karl-Heinz ; Bold, Guido ; Caravatti, Giorgio...
Helvetica Chimica Acta.  85 (2002)  11 - p. 4086-4110 , 2002
Link: https://doi.org/10.1002/..
 
?
14

Convergent synthesis of potent peptide inhibitors of the Gr..:

Schoepfer, Joseph ; Gay, Brigitte ; End, Nicole...
Bioorganic & Medicinal Chemistry Letters.  11 (2001)  9 - p. 1201-1203 , 2001
Link: https://doi.org/10.1016/..
 
?
15

Tyrosine kinase inhibitors: From rational design to clinica..:

Traxler, Peter ; Bold, Guido ; Buchdunger, Elisabeth...
Medicinal Research Reviews.  21 (2001)  6 - p. 499-512 , 2001
Link: https://doi.org/10.1002/..
 
1-15